Effectiveness of Disease-Specific Cognitive Behavioral Therapy on Anxiety, Depression, and Quality of Life in Youth With Inflammatory Bowel Disease: A Randomized Controlled Trial
Open Access
- 29 May 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pediatric Psychology
- Vol. 43 (9) , 967-980
Abstract
To evaluate the effectiveness of a disease-specific cognitive behavioral therapy (CBT) protocol on anxiety and depressive symptoms and health-related quality of life (HRQOL) in adolescents and young adults with inflammatory bowel disease (IBD). A parallel group randomized controlled trial was conducted in 6 centers of (pediatric) gastroenterology. Included were 70 patients and young adults (10–25 years) with IBD and subclinical anxiety and/or depressive symptoms. Patients were randomized into 2 groups, stratified by center: (a) standard medical care (care-as-usual [CAU]) plus disease-specific manualized CBT (Primary and Secondary Control Enhancement Training for Physical Illness; PASCET-PI), with 10 weekly sessions, 3 parent sessions, and 3 booster sessions (n = 37), or (b) CAU only (n = 33). Primary analysis concerned the reliable change in anxiety and depressive symptoms after 3 months (immediate posttreatment assessment). Exploratory analyses concerned (1) the course of anxiety and depressive symptoms and HRQOL in subgroups based on age, and (2) the influence of age, gender, and disease type on the effect of the PASCET-PI. Overall, all participants improved significantly in their anxiety and depressive symptoms and HRQOL, regardless of group, age, gender, and disease type. Primary chi-square tests and exploratory linear mixed models showed no difference in outcomes between the PASCET-PI (n = 35) and the CAU group (n = 33). In youth with IBD and subclinical anxiety and/or depressive symptoms, preliminary results of immediate post-treatment assessment indicated that a disease-specific CBT added to standard medical care did not perform better than standard medical care in improving psychological symptoms or HRQOL. ClinicalTrials.gov: NCT02265588.Keywords
Funding Information
- NIH
This publication has 49 references indexed in Scilit:
- Severity classification on the Hamilton depression rating scaleJournal of Affective Disorders, 2013
- Effects of psychotherapy for anxiety in children and adolescents: A meta-analytic reviewClinical Psychology Review, 2012
- Short pediatric Crohnʼs disease activity index for quality improvement and observational researchInflammatory Bowel Diseases, 2011
- A Meta-analytic Review of the Psychosocial Adjustment of Youth with Inflammatory Bowel DiseaseJournal of Pediatric Psychology, 2010
- Pediatric Inflammatory Bowel Disease: Highlighting Pediatric Differences in IBDGastroenterology Clinics of North America, 2009
- Anxiety and Anxiety Disorders in Children and Adolescents: Developmental Issues and Implications for DSM-VPsychiatric Clinics of North America, 2009
- Childhood and Adolescent Psychiatric Disorders as Predictors of Young Adult DisordersArchives of General Psychiatry, 2009
- Drie vragenlijsten voor diagnostiek van depressie en angststoornissenTBV – Tijdschrift voor Bedrijfs- en Verzekeringsgeneeskunde, 2005
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960